ARNI

Arno Therapeutics (CE) (ARNI)

Arno Therapeutics Inc (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:ARNI

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2018/01/04	07 : 21	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/04/03	19 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/04/03	19 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/03/29	06 : 05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/03/29	06 : 00	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/03/29	05 : 59	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/02/15	07 : 58	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/02/15	07 : 26	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/02/15	06 : 57	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/01/10	02 : 51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/01/10	02 : 50	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/01/06	04 : 21	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/01/04	06 : 28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2017/01/04	06 : 27	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/11/19	06 : 02	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/11/15	06 : 14	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/11/05	05 : 42	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/11/04	19 : 04	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/11/04	19 : 02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/10/13	04 : 05	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/10/06	06 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/09/09	05 : 12	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/09/09	05 : 09	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/09/09	05 : 08	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/09/09	05 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/09/09	05 : 03	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/09/09	05 : 03	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/08/31	04 : 10	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/08/23	06 : 24	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:ARNI	Arno Therapeutics Inc (CE)
2016/08/23	06 : 12	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ARNI	Arno Therapeutics Inc (CE)